Divi's Laboratories Limited vs Earkart Limited

A side-by-side comparison of Divi's Laboratories Limited (DIVISLAB) and Earkart Limited (EARKARTLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads DIVISLAB vs EARKARTLTD on 8 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth02
  • Size & financial health30
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.52
P/E ratio
0.00
14.90
P/B ratio
2.94
0.32%
Dividend yield
0.00%
₹96.75
EPS
₹6.59

Profitability

DIVISLAB takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.32%
Return on equity
11.70%
20.35%
Return on capital
45.13%
32.59%
EBITDA margin
22.71%
24.32%
Net margin
15.96%

Growth

EARKARTLTD takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
23.17%
12.09%
Profit CAGR (3Y)
60.73%

Size & financial health

DIVISLAB takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.45L Cr
Market cap
₹190 Cr
₹10,560 Cr
Revenue
₹43 Cr
₹2,568 Cr
Net profit
₹7 Cr
0.00
Debt / equity even
0.00
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.60 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Earkart Limited
  • + ["Company has reduced debt.", "Company is almost debt free."]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend", "Working capital days have increased from 161 days to 237 days"]
Divi's Laboratories Limited full analysis Earkart Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVISLAB vs EARKARTLTD: Share Price, Valuation & Which to Buy | DocStoX